SCHEMBL4553594

SCHEMBL4553594

Cc1nn(C)c(-n2ccc3cc(F)ccc32)c1/C=C/C=O.[KH]

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KCNH2 Q12809 1/20 0.33
PLK2 Q9NYY3 2/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
MAPT P10636 1/20 0.31
PLK1 P53350 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554908 0.91 CDC7 (0.37) HTR2AHTR2CMAPT
SCHEMBL962714 0.88 ALDH1A1 (0.38) KDM4EALDH1A1HPGDHSD17B10KCNH2
SCHEMBL4554187 0.87 HTR2A (0.33) HTR2AHTR2C
SCHEMBL4553471 0.86 SMN1; SMN2 (0.38) KDM4EALDH1A1HPGDHTR2AHTR2C
SCHEMBL4565958 0.85 ROCK1 (0.41) KDM4EALDH1A1HPGDHSD17B10HTR2C
SCHEMBL962979 0.84 ALDH1A1 (0.46) KDM4EALDH1A1HPGDHSD17B10KCNH2
SCHEMBL966011 0.84 KDM4E (0.34) KDM4EALDH1A1HPGDHSD17B10KCNH2
SCHEMBL966013 0.84 KDM4E (0.34) KDM4EALDH1A1HPGDHSD17B10KCNH2
SCHEMBL962977 0.84 ALDH1A1 (0.46) KDM4EALDH1A1HPGDHSD17B10KCNH2
SCHEMBL4554759 0.84 SMN1; SMN2 (0.38) KDM4EALDH1A1HPGDHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118066-A1 FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA Takeda Pharmaceutical Company Limited (JP) 2009-11-18 EP disclosed
WO-2008099794-A1 FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-08-21 WO disclosed